Sign in
Taking people in United StatesNo phase

Smartphone Sound Test for Lung and Airway Conditions

Tests whether smartphone sounds can assess airways in people with lung disease.

Key facts

Who runs it
Indiana University
Where
Indianapolis and Pittsburgh, United StatesSee the 2 sites
Trial code
Registry title
Acoustic Waveform Respiratory Evaluation
Status
Recruiting
People taking part
800 people, planned
Started
23 Jul 2024
Expected to end
Apr 2029
Type of study
Interventional, 5 groups
Treatments tested
  • AWARE
Record updated
5 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with asthma, COPD, cystic fibrosis or other airway diseases, and healthy volunteers, to test a smartphone sound method for checking the airways.

Age
8 to 70 years (up to 75 years for COPD patients in one adult clinic only).
Sex
Men and women can join.
Disease stage
Doctor-diagnosed asthma, COPD, cystic fibrosis or other airway diseases. Healthy volunteers must have no respiratory or other major disease.

Main reasons for not taking part

  • Cannot or will not do the AWARE test, spirometry or oscillometry
  • Acute or chronic illness that may affect lung function or change the test results

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age 8-70 years (to ensure ability to perform other PFTs; up to 75 years for COPD subjects in the UPMC adult clinic only)
  • Ability to perform spirometry and oscillometry
  • Signed informed consent (and assent for children as appropriate)
  • No respiratory or other major disease (for healthy controls), or physician-diagnosed asthma, COPD, CF, or other airway diseases

Who cannot take part

  • Acute or chronic illness that, at the judgement of investigators, may affect lung function and alter the results of AWARE or the reference PFTs (spirometry and AOS)
  • Inability or unwillingness to perform AWARE, spirometry, or oscillometry

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 70 years old?

Where in United States

  • Indiana UniversityIndianapolis, United StatesContact: Erick Forno, MD MPHTaking people
  • University of PittsburghPittsburgh, United StatesContact: Juan C Celedón, MD DrPHTaking people

About the trial

What the trial wants to find out

The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.

The 5 groups in the trial

  • AsthmaTreatment being tested

    Physician diagnosis plus at least one of the following in the past year: asthma symptoms that improve with albuterol; prescribed asthma controller medication(s); an acute asthma exacerbation requiring systemic steroids; or an emergency department visit or hospitalization for asthma. Alternatively, report of current asthma symptoms per US NAEPP or Global Initiative for Asthma (GINA) guidelines, plus documentation of bronchodilator response or airway hyperresponsiveness.

    Treatment: AWARE

  • Chronic Obstructive Pulmonary Disease (COPD)Treatment being tested

    Physician diagnosis, plus symptoms of COPD per GOLD guidelines, plus post-bronchodilator FEV1/FVC \<0.70 or below the lower limit of normal (LLN) using GLI reference equations.

    Treatment: AWARE

  • Cystic Fibrosis (CF)Treatment being tested

    Physician diagnosis based on U.S. CF Foundation guidelines, including signs/symptoms of CF and either a positive sweat chloride test (\>60 mmol/L), or an indeterminate sweat chloride test (30-59 mmol/L) plus two CF-causing CFTR mutations. The study may include subjects with different CFTR mutation classes as well as both on and off CFTR modulators.

    Treatment: AWARE

  • Other Airway DiseasesTreatment being tested

    This group will include subjects with airway ciliary motility disorders, bronchiectasis, and airway malaria. Given variability in the clinical presentation and diagnosis of these conditions, they will be ascertained by physician diagnosis and reviewed by study physician investigators.

    Treatment: AWARE

  • Healthy ControlsTreatment being tested

    This will include generally healthy subjects who do not have any of the airway diseases included in the study, nor other chronic cardiorespiratory or other diseases that may alter lung function or the ability to participate in the study.

    Treatment: AWARE

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Advancing Telemedicine in Pulmonology: Acoustic-waveform Respiratory Evaluation (AWARE) Via Sensing and Machine Learning on Smartphones
Plain-language title
Smartphone Sound Test for Lung and Airway ConditionsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06512064, who can take part
Record updated
5 October 2026